Fig. 13
From: Characterization and prognostic of CD8 + TIM3 + CD101 + T cells in glioblastoma multiforme
Differences in TMB and drug sensitivity between high-risk and low-risk groups. (A) The top 20 genes with the highest mutation frequencies in the high-risk group and (B) in the low-risk group. (C) Difference in TMB between high-risk and low-risk groups. Violin plots showcasing differences in drug sensitivity between high-risk and low-risk groups, including Bortezomib_1191 (D), Camptothecin_1003 (E), Dactinomycin_1811 (F), Daporinad_1248 (G), Eg5_9814_1712 (H), Luminespib_1559 (I), MG-132_1862 (J), Sepantronium bromide_1941 (K), and Staurosporine_1034 (L) are illustrated